Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.75%
#4 Black Phoenix Black Phoenix +335.99%
#5 aPriori aPriori +116.11%
#6 Bedrock Bedrock +74.68%
#7 Cysic Cysic +47.27%
#8 Prom Prom +42.47%
#9 Playnance Playnance +34.82%
#10 COTI COTI +30.34%
Coin of the day
Wrapped One Wrapped One
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc.

VRPX
Classifica tra le azioni #42776
Virpax Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical... Virpax Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical enterprise, dedicated to pioneering diverse drug-delivery systems and novel drug-releasing technologies. Its core focus lies in developing advanced, non-opioid and non-addictive solutions for pain management, alongside therapies targeting central nervous system disorders. The company's current investigational pipeline features several preclinical product candidates. These include Epoladerm, a topical nonsteroidal anti-inflammatory drug (NSAID) designed to address chronic osteoarthritis of the knee, and Probudur, an injectable liposomal gel formulated as a local anesthetic for managing post-operative pain. Also in development are Envelta and PES200, both nanotechnology-based intranasal spray drug candidates engineered to deliver metabolically labile peptide drugs directly to the brain. Further candidates comprise AnQlar, an antiviral barrier solution intended to prevent or lessen the severity of human viral infections such as influenza and SARS-CoV-2, and VRP324, an experimental nasal formulation aimed at enhancing the transport of cannabidiol into the brain. Virpax Pharmaceuticals, Inc. was established in 2016 and is based in Berwyn, Pennsylvania.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$124.00
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-99.09%
Paese
US
Scambia Virpax Pharmaceuticals, Inc. (VRPX)

Categoria

Healthcare
Storico del prezzo dell'azione per Virpax Pharmaceuticals, Inc. (VRPX)
Prezzo di chiusura più alto: $0.00 il 2026-08-01

Prezzo di chiusura più basso: $1.50K il 2021-02-01
Storico del prezzo dell'azione di Virpax Pharmaceuticals, Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -45.38%
2025 -99.76%
2024 -90.10%
2023 -52.53%
2022 -79.82%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 36.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 37.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 8.73%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 20.45%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -5.56%
KR